Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q3 2015 · 10-Q
Revenue$109.00K$109.00K−58.2% vs Q3 2014 Net Income-$2.09M-$2.09MN/M vs Q3 2014 EPS Diluted-$0.05-$0.05N/M vs Q3 2014 Operating Income-$2,100,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,368,000N/M Margins · derivedOperating margin-1926.6%−1089.8 pt vs Q3 2014
Net margin-1918.3%−1133.3 pt vs Q3 2014
ended Apr 30, 2015 · filed Jun 11, 2015 · 42 d after period end